https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Efficacy of co-administration of modified apple polysaccharide and probiotics in guar gum-Eudragit S100 based mesalamine mini tablets: a novel approach in treating ulcerative colitis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47745 Wed 25 Jan 2023 15:49:34 AEDT ]]> Effects of antibiotic therapy in primary sclerosing cholangitis with and without inflammatory bowel disease: a systematic review and meta-analysis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:42463 p < 0.002) and smallest with metronidazole (22.7%, p = 0.18). Overall, 8.9% (95% confidence interval: 3.9-13.9) of patients had AEs severe enough to discontinue antibiotic therapy. In PSC patients, antibiotic treatment results in a significant improvement in markers of cholestasis and MRS. Antibiotics, particularly vancomycin, may have a positive effect on PSC either via direct effects on the microbiome or via host-mediated mechanisms.]]> Wed 24 Aug 2022 11:23:40 AEST ]]> Colorectal carcinoma in the course of inflammatory bowel diseases https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36834 Wed 17 Nov 2021 16:29:24 AEDT ]]> Efficacy of resveratrol encapsulated microsponges delivered by pectin based matrix tablets in rats with acetic acid-induced ulcerative colitis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49740 Tue 30 May 2023 14:40:41 AEST ]]> Markers of Hypoxia Correlate with Histologic and Endoscopic Severity of Colitis in Inflammatory Bowel Disease https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:40879 Tue 19 Jul 2022 14:31:20 AEST ]]> Mining the microbiome and microbiota-derived molecules in inflammatory bowel disease https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49092 Thu 04 May 2023 15:02:47 AEST ]]> Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:12376 2.5 g/day do not appear to lead to higher remission rates.]]> Sat 24 Mar 2018 10:34:56 AEDT ]]> Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:13924 −11, odds ratio (OR) = 1.32), with the A allele (coding for histadine) conferring elevated disease risk. The second locus is at 19q13, (P = 2.51 x 10⁻⁹, OR = 1.42 for the rs2233152 SNP near MIA and RAB4B; P = 1.68 x 10⁻¹², OR = 1.52 for rs28493229 in ITPKC), which confirms previous findings¹. The involvement of the FCGR2A locus may have implications for understanding immune activation in Kawasaki disease pathogenesis and the mechanism of response to intravenous immunoglobulin, the only proven therapy for this disease.]]> Sat 24 Mar 2018 08:24:48 AEDT ]]> Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:12400 Sat 24 Mar 2018 08:15:46 AEDT ]]> Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:12403 Sat 24 Mar 2018 08:15:46 AEDT ]]> Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:12402 Sat 24 Mar 2018 08:15:46 AEDT ]]> Overlap: irritable bowel syndrome, inflammatory bowel disease, and diverticular disease https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:12396 Sat 24 Mar 2018 08:15:45 AEDT ]]> Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:12431 Sat 24 Mar 2018 08:15:28 AEDT ]]> An evidence-based systematic review on medical therapies for inflammatory bowel disease https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:12436 Sat 24 Mar 2018 08:15:27 AEDT ]]> Selective Th2 pattern of cytokine secretion in Mycobacterium avium subsp paratuberculosis infected Crohn's disease https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:5116 Sat 24 Mar 2018 07:48:57 AEDT ]]> Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease – A Systematic Review https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48101 Fri 24 Feb 2023 15:38:03 AEDT ]]>